← Evidence map

ArticlemAbs

A new class of bispecific antibodies to redirect T cells for cancer immunotherapy.

Diane L Rossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
cites it
Full record →Abstract, authors, funding and every citing paper · PMID 24492297